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Abstract
Introduction: Merkel cell carcinoma is a rare and aggressive primary cutaneous neuroendocrine
malignant tumor. The tumor has a high rate of local recurrence after surgical removal. Spontaneous
regression appears to be relatively common in this rare type of tumor.
Case presentation: We describe the clinical course, cytological and histological findings of a Merkel
cell carcinoma in a 70-year-old Caucasian woman, simultaneously diagnosed with chronic lymphatic
leukemia. The tumor showed clinical regression after fine needle aspiration. At primary presentation,
the tumor had no apparent leukocyte infiltration, but was completely cleared by T-cell mediated
immunity within 3 weeks after fine needle aspiration.
Conclusion: Fine needle aspiration may have acted as a mechanical trigger involved in the activation
of cell-mediated immunity, leading to the clinical and histological regression of the tumor. To the best
of our knowledge, this is the first case report of spontaneous regression of Merkel cell carcinoma in a
patient with a co-malignancy, that is to say, chronic lymphocytic leukemia.
Introduction
Merkel cell carcinoma (MCC) is a rare, aggressive skin
tumor known for its high rate of recurrence, metastasis
formation and consequently, mortality [1]. It is a primary
cutaneous neuroendocrine malignant tumor [2] and
commonly occurs in sun-exposed areas of the body,
mostly in the head and neck region (65%), even though
the upper extremities are involved in 18% and the lower
extremities in 13% of cases [3]. The clinical presentation of
MCC is usually painless, firm, erythematous, intradermal
or subcutaneous nodules without ulceration [4]. Accord-
ing to the literature, co-malignancies are associated with a
higher rate of mortality. The most common ones are other
types of skin tumors and hematological malignancies [5].
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regression has been reported in several cases, with an
estimated prevalence of 1.7% to 3% [6,7].
We describe the clinical course, cytological and histologi-
cal findings of MCC in a 70-year-old woman, simulta-
neously diagnosed with chronic lymphatic leukemia
(CLL). The tumor has shown clinical regression after fine
needle aspiration (FNA). To the best of our knowledge,
this is the first case report of spontaneous regression of
MCC in a patient with hematological co-malignancy,
although spontaneous regression of MCC has been
reported earlier in 89-year-old man with a solid co-
malignancy of lung adenocarcinoma [8].
Case presentation
We present a 70-year-old Caucasian woman with a rapidly
growing tumor on her right forearm (Figure 1A), which
had appeared 2 months earlier, allegedly after an
unidentified insect bite. A few weeks later, she noticed a
small red nodule in that area. During the next few weeks,
the nodule started growing rapidly so she was referred to
our hospital. She had no other complaints. Physical
examination revealed a solitary, firm, non-ulcerated,
livid-red nodule 3 cm in diameter. The regional lymph
nodes were not enlarged. Routine hematology tests
revealed an elevated white blood cell (WBC) count (17 ×
10
9/L) with 75% lymphocytes, suggesting a lymphopro-
liferative disorder.
Fine needle aspiration (FNA) was performed in two
separate areas of the nodule and smears were stained in
accordance with the May-Gruenwald-Giemsa method.
Both specimens showed an abundance of relatively
monomorphic, atypical, epithelial-appearing cells without
visible nucleoli, lying alone and in clusters. Occasional
mitoses were evident. There were a few lymphoid cells in
the background, very scant fibrous stroma and some
peripheral blood. Nuclear molding was prominent in
these cells and the cytoplasm was scant and rarely
preserved (Figure 2A). Malignant cells showed strong
staining with epithelial antigen (Ber-Ep4) (Figure 2B),
while leukocyte common antigen (LCA) was used for
leukocytes. Malignant cells showed strong positivity for
epithelial marker, while LCA marked only a few scattered
lymphoid cells in the background. Diagnosis of epithelial
malignant tumor with neuroendocrine morphologic
features indicated Merkel cell carcinoma.
Simultaneously with the FNA of the cutaneous tumor, a
peripheral blood smear was analyzed. This showed a
lymphocytosis (75% of lymphocytes). Bone marrow
aspiration and flow cytometric analyses confirmed the
diagnosis of a low-grade B-cell chronic lymphocytic
leukemia. Right axillary region ultrasound indicated two
enlarged lymph nodes which showed reactive changes on
histopathological examinations. Further diagnostic tests
did not reveal lymphadenopathy, hepatomegaly or
splenomegaly. Whole body skeletal scintigraphy imaging
Figure 1. Clinical presentation of tumor. (A) 70-year-old
Caucasian woman with a rapidly growing tumor on her right
forearm, which had appeared 2 months earlier, allegedly after
an unidentified insect bite. (B) Spontaneous clinical regression
of the tumor.
Figure 2. Cytopathological examination of the tumor and
regression lesion. (A) Fine needle aspiration - abundant
cellularity, clusters of atypical cells without visible nucleoli,
prominent nuclear molding (May-Gruenwald-Giemsa ×200,
insert x1000). (B) Immunostaining for Ber-Ep4
(×200, insert ×1000). (C) Immunohistochemical labeling
of infiltrating lymphocytes showed a dense infiltrate of
CD3+ cells (pan-T cell) (×400). (D) Immunohistochemical
labeling showed a dense infiltrate of CD68+ cells
(monocytes/macrophages) (×400).
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in Rai stage 0, so there was no need for active treatment.
During 3 weeks of hospital treatment, we noticed the
spontaneous regression of the tumor to half of its original
size (Figure 1B). Surgical excision and sentinel lymph
node biopsy were then carried out. Radical excision with
2 cm of tumor-free margins was performed under general
anesthesia. The sentinel lymph nodes did not contain
MCC.
Histopathological analysis of the regressed tumor, stained
with hematoxylin and eosin, revealed that the tumor cells
were completely replaced by mononuclear cells. An
immunohistochemical study was performed with forma-
lin-fixed and paraffin embedded material, using the
avidin-biotin peroxidase method (all antibodies from
Dako Japan, Co. Ltd, Kyoto). Immunolabeling of infiltrat-
ing lymphocytes was positive for CD3+ T cells (Figure 2C),
while there were a few B cells. Infiltrating macrophages
were positive for CD68+ (Figure 2D). Electronic micro-
scopy of the excised tumor showed histiocytic infiltration,
with no trace of epithelial cells (Figure 3).
The patient was discharged from hospital 7 days after the
surgery and was referred to local radiotherapy. She was re-
admitted to our hospital for an evaluation 6 months after
the initial presentation. Her CLL was stable. Results of an
FNA around the excision site showed no recurrence of the
tumor and no lymph node involvement was noticed.
Discussion
This case report represents the first case of a spontaneous
regression of MCC in a patient with a hematological co-
malignancy, CLL. So far, several studies have reported the
appearance of MCC in patients with CLL [9-12], but none
with MCC as the first presentation. Furthermore, in all of
the previously reported cases of spontaneous regression,
the tumor was localized in the head and neck region
[6-13], while in our example, the tumor site was on the
right forearm.
The incidence of MCC is high (8%) among immunosup-
pressed patients [2], but the pathogenetic relationship
between CLL and cutaneous neoplasia is still unclear. Both
UV radiation and CLL are thought to cause immunosup-
pression which is associated with an increased incidence of
cutaneous malignancies.
In our patient, these factors were combined with another
possible trigger - an insect bite, generating an inflamma-
tory milieu from which MCC could have derived. The fact
that the tumor developed a few weeks after the insect bite,
favors this line of thought.
A better prognosis has been associated with shorter
intervals between the appearance of CLL and development
of MCC, even though the outcome of MCC is possibly
independent of the CLL stage [14]. Poor prognostic factors
are young age, male sex, large tumor size, truncal site,
nodal or distant disease and duration of the disease before
presentation [2,15]. Considering these parameters, a
favorable outcome would be expected in our patient.
Regression is a complete or partial disappearance of
malignant cells without any treatment. It is mediated by
T-lymphoid infiltration which induces apoptotic tumor
cells [16]. A high proportion of MCC shows regression
(1.7 to 3%) in MCC patients [17] so immunologic
responses play an important role in this type of tumor.
It is still unclear how a mechanical stimulus (FNA) can be
a trigger for activating the immune system toward
macrophage mediated digestion of malignant cells. All
previously described cases of MCC regression without any
treatment were also noticed after needle biopsy. This
procedure could stimulate the immune system toward
tumor destruction. Our findings indicate that FNA is
responsible for the activation of cell-mediated immunity,
leading to clinical and histological regression of the tumor.
Results of our histological examination showed that the
tumor cells were completely replaced by mononuclear
cells. Immunohistological staining showed that the
majority of cells were CD3+ T-lymphocytes and CD 68+
macrophages, while there were a few B-lymphocytes.
Figure 3. Electronic microscopy of the excised tumor.
Histiocytic lesion: giant cell with irregular cytoplasmic sprouts.
Erythrophagocytes with large mitochondria, lysosomes, rough
endoplasmatic reticulum and some lipid drops were found in
the cytoplasm. Electron microscopy: ×7100.
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containing phagocytosed tumor cells. Our pathohistolo-
gical findings point to the fact that spontaneous regression
is due to the T-cell mediated immunity, which is the case
with our patient who suffers from an early stage B cell
leukemia. This is consistent with the work of Maruo et al.,
who suggested that T-cell immunity plays an important
role in spontaneous regression of MCC. In their case,
tumor cells were also replaced by macrophages [13].
Conclusion
We should draw attention to the possibility of fine needle
aspiration being a trigger of regression. This suggests that
Merkel cell carcinoma is highly responsive to immuno-
logic reactions, so a possible next step to consider in its
treatment could be immunotherapy.
At this point, many questions still remain unanswered and
additional case reports are necessary to shed light on the
mechanisms of spontaneous regression of MCC.
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